What is Fibrosis?
Fibrosis is the abnormal accumulation of collagen and other extracellular matrix components in tissue, representing excessive scar formation that can lead to organ dysfunction and failure. 1
Core Definition and Pathophysiology
Fibrosis represents a pathological deviation from normal wound healing, characterized by:
- Excessive deposition of structural and matricellular proteins in the extracellular space 2
- Transformation of resting fibroblasts into myofibroblasts that produce excessive extracellular matrix 3
- A process that can affect virtually any organ system including heart, lung, liver, kidney, skin, and bone marrow 3, 4
The condition is always a sequela of inflammatory processes, regardless of the underlying cause 5. Multiple etiologies channel into the same stereotypical pathways, including acute and chronic ischemia, hypertension, chronic viral infection, environmental exposures, and genetic diseases 3.
Types of Fibrosis
Fibrosis can be classified based on cellular activity:
- Active fibrosis: Abnormal collagen accumulation with increased stromal cells (fibroblasts or myofibroblasts) 1
- Inactive fibrosis: Abnormal collagen accumulation without increased stromal cell numbers 1
Clinical Significance
Fibrosis is responsible for up to 45% of all deaths in the industrialized world 6, making it a major contributor to global morbidity and mortality 3. The amount of fibrosis correlates directly with:
- Risk of developing cirrhosis in chronic liver disease 7
- Development of organ-specific complications 7
- Overall prognosis across different organ systems 7
Key Pathogenic Mechanisms
The fibrotic process involves a complex network of cellular interactions:
- Immune cells (predominantly monocytes/macrophages) play central roles 3
- Endothelial cells and parenchymal cells contribute to profibrotic cellular crosstalk 3
- Leading mediators include transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), interleukins (IL-10, IL-13, IL-17), and danger-associated molecular patterns 3, 4
Important Clinical Considerations
Fibrosis was historically thought to be irreversible, but both preclinical models and clinical trials have demonstrated it is a highly dynamic process 6. This plasticity has clear implications for therapeutic interventions, though effective antifibrotic therapies remain limited 2, 4.
The condition differs from desmoplasia, which specifically refers to the cellular fibroinflammatory response accompanying invasive carcinoma and should not be used in the absence of invasive cancer 1.